Intra-Cellular Therapies Inc (NASDAQ:ITCI) belongs to Healthcare sector. Its weekly performance is 4.74%. On last trading day company shares ended up $35.80. Intra-Cellular Therapies Inc (NASDAQ:ITCI) distance from 50-day simple moving average (SMA50) is 31.81%. SunTrust reiterated their buy rating on shares of Intra-Cellular Therapies (NASDAQ:ITCI) in a research note released on Thursday morning. They currently have a $50.00 target price on the biopharmaceutical company’s stock.
Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) shares moved up 2.86% in last trading session and ended the day at $47.77. PTLA return on assets is -41.60%. Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) quarterly performance is 24.05%. On 24 June, Portola Pharmaceuticals (NASDAQ:PTLA) announced results of a study demonstrating that andexanet alfa significantly reduced bleeding in a validated animal model of bleeding using the Factor Xa inhibitor rivaroxaban as the anticoagulant. The reduction in blood loss correlated with reversal of the anticoagulant effects of rivaroxaban as measured by anti-Factor Xa activity, a definitive pharmacodynamic measurement of the anticoagulant activity of Factor Xa inhibitors.
On 13 July, Simulations Plus, Inc. (NASDAQ:SLP) shares advanced 1.48% and was closed at $6.19. SLP EPS growth in last 5 year was 17.60%. Simulations Plus, Inc. (NASDAQ:SLP) year to date (YTD) performance is -6.64%. Simulations Plus (NASDAQ: SLP) reported Q3 EPS of $0.11, $0.02 better than the analyst estimate of $0.09. Revenue for the quarter came in at $5.94 million versus the consensus estimate of $5.56 million.
Ashford Hospitality Trust, Inc. (NYSE:AHT) ended the last trading day at $9.05. Company weekly volatility is calculated as 2.31% and price to cash ratio as 2.57. Ashford Hospitality Trust, Inc. (NYSE:AHT) showed a weekly performance of 2.26%. Ashford Hospitality Trust, Inc. (NYSE:AHT) announced that its Board of Directors has declared the distribution of its remaining units and shares of common stock of Ashford Hospitality Prime, Inc. Ashford Trust currently owns approximately 5.0 million common units of Ashford Hospitality Prime Limited Partnership, the operating partnership of Ashford Prime.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares advanced 0.24% in last trading session and ended the day at $8.24. TNXP return on assets is -66.70%. Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) quarterly performance is 33.98%. Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced that it intends to offer shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.